The Title of the Video Would Go Here

Video: How to Implant the SynCardia Total Artificial Heart
Video: How to Implant the SynCardia Total Artificial Heart

Press Release:

How to Implant the SynCardia Total Artificial
Heart Detailed in Peer Reviewed Paper
and Matching Video

Doctors at Virginia Commonwealth University Medical Center discuss the benefits and use of the SynCardia Total Artificial Heart in a PubMed indexed case report and video that includes implant surgery of 60-year-old man.

Dr. Daniel G. Tang, Virginia Commonwealth University Medical Center assistant professor of cardiothoracic surgery, explains the SynCardia Total Artificial Heart implantation procedure.Dr. Daniel G. Tang, Virginia Commonwealth University Medical Center assistant professor of cardiothoracic surgery, explains the SynCardia Total Artificial Heart implantation procedure.

TUCSON, Ariz. – July 31, 2014 – For the first time, cardiac surgeons, medical professionals and the public can watch the implantation of the SynCardia temporary Total Artificial Heart in a peer reviewed case report paper and matching video posted on the Journal of Visualized Experiments website.

How to Implant the SynCardia Total Artificial Heart Detailed in Peer Reviewed - VideoThe 16-minute video accompanies “Implantation of the SynCardia Total Artificial Heart,” a July 18, 2014 paper by cardiac surgeons at Virginia Commonwealth University Medical Center.

How to Implant the SynCardia Total Artificial Heart - Peer-Reviewed paperThe paper and video both describe the case of a 60-year-old male with hypertrophic cardiomyopathy. Both detail the implantation surgery. They also discuss perioperative complications, postoperative care and selection of good candidates for the procedure.

“Patients often present with cardiogenic shock and multi-system organ dysfunction,” according to the paper by Drs. Daniel G. Tang, Keyur B. Shah, Michael L. Hess and Vigneshwar B. Kasirajan. “Excision of both ventricles and orthotopic replacement with the [SynCardia Total Artificial Heart] is an effective…therapy for rapid restoration of blood flow and resuscitation.”

Heart failure patients who are extremely sick can get a second chance at life with the SynCardia Total Artificial Heart. It is the only approved device that eliminates the source of end-stage biventricular (both sides) heart failure in which the native heart ventricles can no longer pump enough blood for the patient to survive.

“The main advantage of the Total Artificial Heart over left ventricle assist devices [LVADs] is the [SynCardia Total Artificial Heart] allows for high-flow biventricular support,” Tang, VCU assistant professor of cardiothoracic surgery, says in the video, “as well as the ability to treat a wide range of complex cardiac pathology that may not be ideally treated with isolated [LVAD] support.”

The SynCardia Total Artificial Heart is becoming the standard of care for addressing end-stage biventricular heart failure. Says Tang: “Refinements in the current generation SynCardia [Total Artificial Heart], patient selection, management of pericardial space, as well as perioperative management of the patients, have led to a marked improvement in patient outcomes.”

###

 

SynCardia Systems, Inc. in Tucson, Arizona is the privately-held owner and manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart for use as a bridge to transplant for people suffering from end-stage biventricular heart failure in which both ventricles can no longer pump enough blood for a person to survive.

More than 1,350 implants of the SynCardia Total Artificial Heart accounts for over 400 patient years of life on the device. Since January 2011 more than 400 SynCardia Hearts have been implanted.

The youngest patient to receive a SynCardia Heart was 9 years old; the oldest was 76 years old. The longest a patient has lived with a SynCardia Heart was nearly four years (1,374 days) before receiving a successful donor heart transplant Sept. 11, 2011.

SynCardia Systems also manufactures the Freedom® portable driver, which powers the SynCardia Heart while allowing clinically stable patients to leave the hospital to live at home and in their communities. The wearable Freedom driver has been used by more than 200 patients, accounting for over 120 years of support

 

Media Contact:
Don Isaacs
Vice President of Communications
SynCardia Systems, Inc.
Cell: (520) 955-0660

FREE News Sign-Up

3538727_sBe Among the First to
Receive SynCardia News

... right in your email box